TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
TYK Medicines, Inc. Class H ( (HK:2410) ) just unveiled an update.
TYK Medicines, Inc has announced a book closure period for determining shareholder entitlements to attend and vote at an upcoming extraordinary general meeting (EGM). The register of members will be closed from October 24 to October 30, 2025, and shareholders must submit transfer documents by October 23, 2025, to qualify for participation. This meeting is significant as it involves proposed amendments to the company’s articles of association, potentially impacting the company’s governance and strategic direction.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
TYK Medicines, Inc is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company focuses on developing and providing medicinal products, with a market presence that includes listed shares on the Hong Kong Stock Exchange.
Average Trading Volume: 11,118,968
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$6.58B
For detailed information about 2410 stock, go to TipRanks’ Stock Analysis page.